Profilo
Jack Tsai worked as Vice President-Business Development at Inhibrx, Inc. from 2021 to 2022.
He completed his undergraduate degree at the University of Rochester, followed by an MBA from MIT Sloan School of Management.
He also holds a doctorate degree from Tufts University School of Medicine.
Precedenti posizioni note di Jack Tsai
| Società | Posizione | Fine |
|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 01/09/2022 |
Formazione di Jack Tsai
| MIT Sloan School of Management | Masters Business Admin |
| Rochester Christian University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Jack Tsai
